Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CAREMARK, L.L.C.

NPI: 1013998913 · MILFORD, MA 01757 · Durable Medical Equipment & Medical Supplies · NPI assigned 11/08/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official AYCOCK, BRANDON controls 13+ related entities in our dataset. Read more

$2.20M
Total Medicaid Paid
1,575
Total Claims
1,263
Beneficiaries
6
Codes Billed
2018-12
First Month
2023-03
Last Month

Provider Details

Authorized OfficialAYCOCK, BRANDON (PRESIDENT)
NPI Enumeration Date11/08/2005

Related Entities

Other providers sharing the same authorized official: AYCOCK, BRANDON

ProviderCityStateTotal Paid
PROCARE PHARMACY DIRECT, LLC. MONROEVILLE PA $227.31M
PROCARE PHARMACY, L.L.C. HONOLULU HI $41.83M
CAREMARK, L.L.C. MT PROSPECT IL $34.08M
CAREMARK, L.L.C. REDLANDS CA $19.87M
CAREMARK, L.L.C. TAMPA FL $7.28M
CAREMARK, L.L.C. FAIRFIELD NJ $3.43M
CAREMARK L.L.C. RALEIGH NC $2.69M
CAREMARK L.L.C. LENEXA KS $2.54M
CAREMARK, L.L.C. BARTLETT TN $1.96M
PROCARE PHARMACY, LLC. BIRMINGHAM AL $623K
PROCARE PHARMACY, L.L.C. PORTLAND ME $109K
PROCARE PHARMACY LLC BOSTON MA $724.47
CAREMARK, LLC MT. PROSPEC IL $76.40

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 16 $56K
2019 104 $199K
2020 311 $84K
2021 493 $653K
2022 579 $1.06M
2023 72 $140K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
Q9992 Injection, buprenorphine extended-release (sublocade), greater than 100 mg 520 493 $941K
Q9991 Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg 487 459 $885K
J2357 Injection, omalizumab, 5 mg 64 58 $178K
J0585 Injection, onabotulinumtoxina, 1 unit 71 69 $92K
99601 356 147 $80K
99602 Nursing care in home rn 77 37 $20K